Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal antibody that targets the tumor-associated antigen CA-125. Abagovomab is produced by hybridoma cells in mice. Abagovomab can be used to study ovarian cancer.
CAS Number:
[792921-10-9]
Target:
ACA 125
* VAT and and shipping costs not included. Errors and price changes excepted